Get the Stockscreener App
1.78
0.56%
-0.01
After Hours:
1.81
0.03
+1.69%
Metagenomi Inc stock is traded at $1.78, with a volume of 142.37K.
It is down -0.56% in the last 24 hours and down -22.61% over the past month.
Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox. The genome editing toolbox includes systems for making small edits such as programmable nucleases, base editors, small RNA-mediated integration systems (RIGS), as well as large gene integration systems including large template RIGS and CRISPR-associated transposases (CASTs). The company is focused on its vivo gene editing for its wholly-owned pipeline while pursuing technology out licensing for ex vivo cell therapy. Its pipeline includes product candidates aimed at addressing disorders like Hemophilia A (through MGX-001), Refractory Hypertension, Cardiovascular diseases, and Wilson's disease, among others.
See More
Previous Close:
$1.79
Open:
$1.77
24h Volume:
142.37K
Relative Volume:
0.24
Market Cap:
$66.81M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-4.81%
1M Performance:
-22.61%
6M Performance:
-3.78%
1Y Performance:
-36.43%
1-Day Range:
$1.73
$1.8299
1-Week Range:
$1.73
$1.89
52-Week Range:
$1.23
$4.92
Metagenomi Inc Stock (MGX) Company Profile
Name
Metagenomi Inc
Sector
Industry
Phone
(510) 871-4880
Address
5959 HORTON STREET, EMERYVILLE
Compare MGX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MGX
Metagenomi Inc
|
1.78 | 68.31M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Metagenomi Inc Stock (MGX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-07-24 | Initiated | H.C. Wainwright | Buy |
| May-02-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Mar-05-24 | Initiated | BMO Capital Markets | Outperform |
| Mar-05-24 | Initiated | Chardan Capital Markets | Buy |
| Mar-05-24 | Initiated | JP Morgan | Overweight |
| Mar-05-24 | Initiated | Jefferies | Buy |
| Mar-05-24 | Initiated | TD Cowen | Outperform |
| Mar-05-24 | Initiated | Wells Fargo | Overweight |
View All
Metagenomi Inc Stock (MGX) Latest News
Candlestick signals on Metagenomi Inc. stock todayJuly 2025 Trade Ideas & Smart Swing Trading Techniques - Newser
How high can Metagenomi Inc. stock goTrade Volume Report & Risk Controlled Daily Plans - Newser
Applying Elliott Wave Theory to Metagenomi Inc.2025 Market Sentiment & Breakout Confirmation Trade Signals - Newser
Should you hold or exit Metagenomi Inc. nowJuly 2025 Drop Watch & Long Hold Capital Preservation Tips - Newser
What high frequency data says about Metagenomi Inc.Chart Signals & Proven Capital Preservation Tips - Newser
Does Metagenomi Inc. show high probability of rebound2025 Investor Takeaways & Smart Money Movement Tracker - Newser
Can Metagenomi Inc. maintain its current growth rateTrade Analysis Report & Risk Adjusted Swing Trade Ideas - khodrobank.com
Will Metagenomi Inc. outperform its industry peersJuly 2025 Sector Moves & Real-Time Volume Triggers - khodrobank.com
Is Metagenomi Inc. stock a buy or sellTrade Entry Report & Community Supported Trade Ideas - khodrobank.com
What technical models suggest about Metagenomi Inc.’s comebackPortfolio Growth Summary & Accurate Entry and Exit Point Alerts - Newser
Technical signs of recovery in Metagenomi Inc.Quarterly Profit Review & Real-Time Buy Signal Notifications - Newser
Chart based analysis of Metagenomi Inc. trendsJuly 2025 Analyst Calls & Daily Technical Forecast Reports - Newser
Will Metagenomi Inc. stock benefit from AI tech trendsJuly 2025 Spike Watch & Accurate Buy Signal Alerts - Newser
Using Bollinger Bands to evaluate Metagenomi Inc.2025 Year in Review & High Accuracy Trade Alerts - Newser
Can trapped investors hope for a rebound in Metagenomi Inc.Entry Point & Expert Curated Trade Setup Alerts - Newser
Pattern recognition hints at Metagenomi Inc. upside2025 Trade Ideas & Technical Buy Zone Confirmations - Newser
Is Metagenomi Inc. stock ready for a breakout2025 Top Gainers & Weekly High Return Stock Forecasts - Newser
Tick level data insight on Metagenomi Inc. volatilityPortfolio Growth Summary & Accurate Entry and Exit Point Alerts - Newser
Custom strategy builders for tracking Metagenomi Inc.Quarterly Portfolio Review & Weekly Hot Stock Watchlists - Newser
Metagenomi Inc. Stock Fails to Break Resistance Traders ReactWeekly Gains Report & Daily Price Action Insights - beatles.ru
Price momentum metrics for Metagenomi Inc. explainedGap Up & Safe Swing Trade Setups - Newser
Whale Trades: Will Metagenomi Inc. outperform during market ralliesInsider Selling & Weekly Setup with ROI Potential - khodrobank.com
News impact scoring models applied to Metagenomi Inc.Trade Risk Report & Daily Profit Maximizing Tips - Newser
What Fibonacci levels say about Metagenomi Inc. reboundChart Signals & Daily Entry Point Alerts - Newser
Metagenomi, Inc. shares rise 1.72% intraday after Oxford Nanopore Technologies reported strong first half performance. - AInvest
Is Metagenomi Inc. stock poised for growth2025 Market Overview & Risk Managed Investment Entry Signals - Newser
Can Metagenomi Inc. withstand a market correctionWeekly Trade Summary & Long-Term Safe Investment Ideas - khodrobank.com
Regression analysis insights on Metagenomi Inc. performanceJuly 2025 Recap & Expert Curated Trade Ideas - Newser
Metagenomi, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before November 25, 2024 to Discuss Your RightsMGX - ACCESS Newswire
Is Metagenomi Inc. forming a bullish divergenceMarket Movers & Entry Point Confirmation Signals - khodrobank.com
What is the earnings history of Metagenomi Inc.2025 Volume Leaders & AI Powered Market Trend Analysis - khodrobank.com
Metagenomi Inc. stock momentum explained2025 Market WrapUp & High Accuracy Trade Signal Alerts - Newser
Momentum Indicator Shows Bearish Divergence in Metagenomi Inc. getLinesFromResByArray error: size == 0 - 강소기업뉴스
Will Metagenomi Inc. outperform tech stocks2025 AllTime Highs & Weekly Setup with High ROI Potential - khodrobank.com
Trend analysis for Metagenomi Inc. this weekTrade Risk Report & Weekly Top Gainers Trade List - Newser
Automated trading signals detected on Metagenomi Inc.Gap Up & High Accuracy Investment Signals - Newser
What makes Metagenomi Inc. stock price move sharplyWeekly Volume Report & Step-by-Step Swing Trade Plans - Newser
Risk vs reward if holding onto Metagenomi Inc.Gap Up & Weekly High Conviction Ideas - Newser
Metagenomi price target lowered to $11 from $12 at Chardan - MSN
Metagenomi Inc Stock (MGX) Financials Data
There is no financial data for Metagenomi Inc (MGX). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Metagenomi Inc Stock (MGX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Wein Matthew | See Remarks |
Jun 06 '25 |
Sale |
1.75 |
199 |
348 |
16,693 |
| Noonberg Sarah B. | Chief Medical Officer |
Jun 06 '25 |
Sale |
1.75 |
5,239 |
9,168 |
109,135 |
| Wapnick Pamela | Chief Financial Officer |
Jun 06 '25 |
Sale |
1.75 |
1,576 |
2,758 |
72,108 |
| Thomas Brian C. | Chief Executive Officer |
Jun 06 '25 |
Sale |
1.75 |
10,785 |
18,874 |
2,517,491 |
| Irish Jian | See Remarks |
Jun 06 '25 |
Sale |
1.75 |
6,390 |
11,182 |
315,543 |
| Wein Matthew | See Remarks |
Mar 05 '25 |
Sale |
1.87 |
930 |
1,744 |
9,467 |
| Wapnick Pamela | Chief Financial Officer |
Mar 05 '25 |
Sale |
1.87 |
1,808 |
3,390 |
59,684 |
| Wapnick Pamela | Chief Financial Officer |
Dec 05 '24 |
Sale |
1.86 |
1,559 |
2,900 |
61,492 |
| Wapnick Pamela | Chief Financial Officer |
Sep 05 '24 |
Sale |
2.88 |
6,265 |
18,043 |
63,051 |
1.75%
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):